Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts

4 trials 2 recruiting Orphan designation

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

1 Sponsors

8 Countries

Phase III

Phase II

Phase III: 1 Phase II: 3

Sponsors using this IMP

All trials

4 total

A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered c… Recruiting

2023-507717-94-00 Phase III 8 countries Cutiss AG
Medical-scientific research into a new own skin graft product (EHSG-KF) Recruiting

2024-512189-33-00 Phase II 2 countries Cutiss AG
Medical-scientific research into a new own skin graft product (EHSG-KF) Ended

2024-512190-27-00 Phase II 2 countries Cutiss AG
Medical-scientific research into a new own skin graft product (EHSG-KF) Ended

2024-512188-29-00 Phase II 1 country Cutiss AG

Showing 1–4 of 4 trials

← All drugs A–Z